JD Stiegman
More stories
-
Capivasertib combined with Fulvestrant shows promise for advanced Hormone Receptor-positive patients
New Treatment for Patients with Hormone Receptor-Positive, HER2-Negative Breast Cancer Approved Introduction On November 16, 2023, the U.S. Food and Drug Administration approved capivasertib (Truqap) for use in combination with fulvestrant for the treatment of hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer in patients with one or more PIK3CA/AKT1/PTEN alterations. The approval followed […] More
-
FDA Approves EPKINLY to Treat Patients with Follicular Lymphoma in The Weekly Journal
FDA Approves EPKINLY® for Relapsed or Refractory Follicular Lymphoma Introduction AbbVie, one of the leading pharmaceutical companies, recently announced that the U.S. Food and Drug Administration (FDA) has approved EPKINLY® (epcoritamab-bysp) as the first and only bispecific antibody to treat adults with relapsed or refractory (R/R) follicular lymphoma (FL) after two or more lines of […] More
-
Mushroom Microdosing: Moms Tout Benefits But Doctor’s Warn of Risks
Mushroom Microdosing: Can It Help Mothers with Stress and Anxiety? A Growing Trend in Psychedelic Therapy Microdosing of “magic” mushrooms, or psilocybin, is a growing trend among mothers seeking relief from their daily stress and anxiety. According to some reports, thousands of women are taking small, sub-hallucinogenic doses of these psychedelic substances to improve their […] More
-
Glofitamab GemOx Outperforms Rituximab GemOx in Lymphoma
Glofit-GemOx Superior to Rituximab-GemOx in Treating Relapsed/Refractory DLBCL The annual hybrid congress of the European Hematology Association was held in Madrid from June 13-16, where a study was presented showing that Glofitamab (Glofit) plus gemcitabine and oxaliplatin (GemOx) was superior to rituximab (R)-GemOx for relapsed/refractory (R/R) diffuse large B-cell lymphoma (DLBCL). The study examined the […] More
-
Trending
Investors Embrace Momentum of Lymphoma Drug Developer Kursiv.kz
Citius Pharmaceuticals Pharmaceuticals Completes Trials and Prepares for Launch of Drugs Citius Pharmaceuticals is a developer of critical care products such as drugs for bloodstream infections, lymphoma, and hemorrhoids. The company’s shares recently surged over 10% after it announced the completion of trials for one of its drugs and its readiness to launch another. Citius […] More
-
“Active License List 071024: Find Out Which Licenses Are Currently Valid”
How Alternative Medicines Can Affect Healthcare Treatment Alternative medicines have been used for centuries as a form of healthcare treatment. They provide an alternative to traditional medicine and can be used to treat a range of illnesses and conditions. This article will explore the ways in which alternative medicines can affect healthcare treatment and provide […] More
-
Join Fred Hutch Obliteride on August 10 for Biking, Walking, Running, and Fundraising!
Obliteride Seattle 2024: Raising Funds for Cancer Prevention, Detection, Treatment and Cures Introduction Seattle, July 11, 2024 – The Fred Hutch Cancer Center’s annual Obliteride bike ride and 5K walk/run is all set to witness a new record this year. Obliteride is inviting participants from across the nation to join the event on Aug. 10th, […] More
-
Trending
“Beyond Traditional Cancer Treatment: Kevin MD Podcast”
The Role of Integrative Therapies in Cancer Care Introduction Cancer treatment can be overwhelming and traumatic, both physically and emotionally. As a healthcare professional, it is essential to acknowledge and utilize the benefits of complementary therapies to enhance the overall care of cancer patients. In this article, we explore the growing interest in holistic approaches […] More
-
Trending
Insurers accused of $50B fraud linked to Medicare Advantage plans
Insurers Accused of $50B Fraud Connected to Medicare Advantage Plans Introduction Private insurers who offer Medicare Advantage Plans for seniors covered under Medicare are accused of defrauding taxpayers to the tune of $50 billion between 2019 and 2021. This report from the Wall Street Journal shows that Medicare Advantage made “hundreds of thousands of questionable […] More
-
Illuminating the Surfaceome: A Path to Targeted Cancer Therapies?
The Importance of Surface Proteins in Precision Oncology Precision oncology has revolutionized cancer treatment by providing targeted therapies that tackle the specific genetic or molecular alterations in cancer cells. At the heart of this approach lies the identification of surface proteins located on the cell membrane of tumor cells. Roman Thomas, CEO of DISCO Pharmaceuticals, […] More
-
Trending
5 Biotech Stocks Under $10 With Multibagger Potential
The Promising Biotech Industry, Strong Buy Stocks and Upside Potential The biotech industry is dynamic and pivotal in revolutionizing healthcare. With the development of innovative drugs that target critical, unmet medical needs, biotech companies are shaping a future where new treatments offer hope and solutions previously unimaginable. According to projections, the global biotechnology market is […] More
-
Trending
Elderly Itch Relief: Drug-Free Autophagy Activation by Cureus
Alternative Medicine: A Comprehensive Overview Introduction: Understanding Alternative Medicine Alternative medicine, also known as complementary or integrative medicine, refers to a group of diverse medical and healthcare practices, products, and systems that are not considered to be part of conventional medicine. While conventional medicine focuses on diagnosis, treatment, and prevention of disease using drugs and […] More
Load More
Congratulations. You've reached the end of the internet.